| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 03/03/2005 | WO2005019171A1 Substituted indole derivatives for pharmaceutical composition for treating respiratory diseases |
| 03/03/2005 | WO2005019170A1 Novel process for preparation of 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1h-indol-2-yl]-3, 5-dihydroxy-6-heptenoic acid sodium salt |
| 03/03/2005 | WO2005019169A2 Indoline derivatives as ppar-delta modulators |
| 03/03/2005 | WO2005018636A1 (4-hydroxyphenyl)-1h-indole-3-carbaldehyde oxime derivative as estrogenic agents |
| 03/03/2005 | WO2005018561A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 03/03/2005 | WO2005018531A2 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof |
| 03/03/2005 | WO2005003098B1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents |
| 03/03/2005 | WO2005000803A3 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst |
| 03/03/2005 | WO2004039894A3 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 03/03/2005 | US20050049384 Novel approach to reduce cyclics formation in 3-CIPA based polyetherimide polymers |
| 03/03/2005 | US20050049296 Process for the synthesis of cPLA2 inhibitors |
| 03/03/2005 | US20050049295 Process for the preparation of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1piperazinyl) ethyl)-6-chloro-1, 3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride) and its intermediate |
| 03/03/2005 | US20050049277 Histamine H3 receptor antagonists; such as 2-(4-(n-ethyl)anilinoethoxyphenyl)imidazo[1,2-a]pyridine |
| 03/03/2005 | CA2536173A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 03/03/2005 | CA2535960A1 Indoline derivatives |
| 03/03/2005 | CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/03/2005 | CA2535341A1 (4-hydroxyphenyl)-1h-indole-3-carbaldehyde oxime derivative as estrogenic agents |
| 03/02/2005 | EP1509518A1 Calcium receptor modulating agents |
| 03/02/2005 | EP1509509A1 Glucagon antagonists/inverse agonists |
| 03/02/2005 | EP1509504A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 03/02/2005 | EP1509502A1 Method of forming a carbon-carbon or carbon-heteroatom linkage |
| 03/02/2005 | EP1509501A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509224A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia |
| 03/02/2005 | EP1509216A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
| 03/02/2005 | EP1042279B1 Substituted beta-alanines |
| 03/02/2005 | EP0844873B1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 03/02/2005 | CN1589272A Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines, intermediates therefore, and processes for preparing such intermediates |
| 03/02/2005 | CN1589270A Indole-2-formamide compounds as factor Xa inhibitors |
| 03/02/2005 | CN1589260A Heterocyclic compounds and methods of use thereof |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/02/2005 | CN1589147A Use of N-(indolecarbonyl-)piperazine derivatives |
| 03/02/2005 | CN1587252A Multiple photon absorptive phenyl fluorene derivative and its preparing method |
| 03/02/2005 | CN1191228C Synthesis method of nitroxymethylphenyl esters of aspirin derivatives |
| 03/02/2005 | CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 03/01/2005 | US6861529 Cycloalkylpyrrole-3-carboxylic acid amide derivatives and heterocycloalkylpyrrole-3-carboxylic acid amide derivatives that bind with high affinity to the benzodiazepine site of GABA-A (gamma-aminobutyric acid) receptors |
| 03/01/2005 | US6861448 Nictoinamide adenine dinucleotide (NAD); microbiocides; antiseptics; plant safening agents; antibiotic resistance; agriculture; food treatment |
| 03/01/2005 | US6861444 Treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; adrenergic blocking agents |
| 03/01/2005 | US6861443 Drugs; modulator of a nicotinic receptor antagonist |
| 03/01/2005 | US6861418 Modulating protein kinase signal transduction; anticancer agents |
| 03/01/2005 | US6861409 Compounds for use in the dtreatment of growth metabolic disorders |
| 03/01/2005 | US6861391 Pesticides and herbicides |
| 03/01/2005 | CA2288334C Method of manufacturing sertindole |
| 03/01/2005 | CA2138287C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/24/2005 | WO2005016922A1 Carbazole-2-carboxamide derivatives having vanilloid receptor antagonist activity |
| 02/24/2005 | WO2005016891A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 02/24/2005 | WO2005016890A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 02/24/2005 | WO2005016882A1 Monomers, oligomers and polymers of 2-functionalized and 2,7-difunctionalized carbazoles |
| 02/24/2005 | WO2005016881A1 Bicyclic indoline sulfonamide derivatives |
| 02/24/2005 | WO2005016875A2 Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein kinase inhibitors |
| 02/24/2005 | WO2005016868A2 Matrix metalloproteinase inhibitors |
| 02/24/2005 | WO2005016867A2 Anthranilic acid derivatives and their use as activators of the hm74a receptor |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016335A1 Indoline-sulfanilic acid amides used as ppar delta modulators |
| 02/24/2005 | WO2005016326A2 Analogs of thalidomide as potential angiogenesis inhibitors |
| 02/24/2005 | WO2004099168A3 Substituted carboxylic acids |
| 02/24/2005 | WO2004093789A3 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 02/24/2005 | WO2004002472A8 Carvedilol hydrobromide |
| 02/24/2005 | US20050043552 Process for the synthesis of amine ethers from secondary amino oxides |
| 02/24/2005 | US20050043509 Peptoid compounds |
| 02/24/2005 | US20050043389 Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 02/24/2005 | US20050043388 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 02/24/2005 | US20050043385 Hydroxyalkylindole derivatives as anticancer agent |
| 02/24/2005 | US20050043371 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 02/24/2005 | US20050043366 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage |
| 02/24/2005 | US20050043348 Phenyl-substituted imidazopyridines |
| 02/24/2005 | US20050043337 Selective beta3 adrenergic agonists |
| 02/24/2005 | US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis |
| 02/24/2005 | US20050043302 New indole derivatives as factor Xa inhibitors |
| 02/24/2005 | US20050043293 Selective maxi-K potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | US20050042407 containing a cyanovinylene group; can be written on or read by blue light, preferably laser light |
| 02/24/2005 | DE10302452B4 Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung Carbonylamino-substituted acyl-phenyl-urea derivatives, processes for their preparation and their use |
| 02/24/2005 | CA2536961A1 Endoluminal prosthesis comprising a therapeutic agent |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2535497A1 Monomers, oligomers and polymers of 2-functionalized and 2,7-difunctionalized carbazoles |
| 02/23/2005 | EP1508566A1 (2s)-2-ethylphenylpropionic acid derivative |
| 02/23/2005 | EP1507758A2 Indole derivatives and their use as ligands for cb2 receptors |
| 02/23/2005 | EP0947507B1 Novel tetrahydrobenzindolone derivatives |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1583722A Heterofluorene highly branched derivative with strong two photon absorption characteristics |
| 02/23/2005 | CN1190432C Piperazing derivatives as 5-HTIB antagonists |
| 02/23/2005 | CN1190421C Method for producing cyclic compounds |
| 02/23/2005 | CN1190420C Non-peptide neomatal vascularization inhibitor |
| 02/22/2005 | US6858741 Use as pesticides and herbicides |
| 02/22/2005 | US6858739 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/22/2005 | US6858738 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 02/22/2005 | US6858689 Polymerization catalyst activators, method of preparing, and their use in polymerization processes |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858643 Crystalline forms of Fluvastatin sodium |
| 02/22/2005 | US6858642 For use in pharmaceutical, skin-protective and cosmetic formulations |
| 02/22/2005 | US6858641 Substituted indolinones |
| 02/22/2005 | US6858622 Cycloalkano-indole and -azaindole derivatives |
| 02/22/2005 | US6858604 Cyclohepta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 02/22/2005 | US6858565 Color developers; recording images |
| 02/22/2005 | US6858073 Transition metal or silicon matrix in which particles of an organic pigment are homogeneously embedded or crosslinked; 3-methylidene-2,3-dihydro-indol-2-ones, quinacridone, indigo, diketopyrrolopyrrole, anthraquinone, perylene; thermostable |
| 02/17/2005 | WO2005014723A1 Cyanin-type compounds having an alkynyl linker arm |
| 02/17/2005 | WO2005014722A1 Cyanine compounds, optical recording materials and optical recording media |
| 02/17/2005 | WO2005014584A1 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis |
| 02/17/2005 | WO2005014544A1 Stable modifications of tegaserod hydrogen maleate |